P
Patchareeya Amput
Researcher at Chiang Mai University
Publications - 14
Citations - 61
Patchareeya Amput is an academic researcher from Chiang Mai University. The author has contributed to research in topics: Medicine & Atorvastatin. The author has an hindex of 3, co-authored 6 publications receiving 16 citations.
Papers
More filters
Journal ArticleDOI
The comparative effects of high dose atorvastatin and proprotein convertase subtilisin/kexin type 9 inhibitor on the mitochondria of oxidative muscle fibers in obese-insulin resistant female rats.
Chanisa Thonusin,Nattayaporn Apaijai,Thidarat Jaiwongkam,Sasiwan Kerdphoo,Busarin Arunsak,Patchareeya Amput,Siripong Palee,Wasana Pratchayasakul,Nipon Chattipakorn,Siriporn C. Chattipakorn +9 more
TL;DR: It is suggested that PCSK9 inhibitor is superior to atorvastatin in instigating weight loss, cholesterol reduction, and attenuation of mitochondrial oxidative stress in oxidative muscle fibers of obese female rats.
Journal ArticleDOI
Impact of COVID-19 Pandemic on Daily Lives, Agricultural Working Lives, and Mental Health of Farmers in Northern Thailand
Ratana Sapbamrer,Jiraporn Chittrakul,Wachiranun Sirikul,Amornphat Kitro,Wilawan Chaiut,Pattarika Panya,Patchareeya Amput,Eakasit Chaipin,Chatchada Sutalangka,Suttinee Sidthilaw,Pornthip Promrak,Pailinrak Kamolsan,Surat Hongsibsong +12 more
TL;DR: In this article , a cross-sectional study was conducted to determine the impact of the COVID-19 pandemic on the daily lives, agricultural working lives, and mental health of farmers in northern Thailand.
Journal ArticleDOI
PCSK9 inhibitor and atorvastatin reduce cardiac impairment in ovariectomized prediabetic rats via improved mitochondrial function and Ca2+ regulation
Patchareeya Amput,Siripong Palee,Busarin Arunsak,Wasana Pratchayasakul,Chanisa Thonusin,Sasiwan Kerdphoo,Thidarat Jaiwongkam,Siriporn C. Chattipakorn,Nipon Chattipakorn +8 more
TL;DR: Findings indicated that the atorvastatin, PCSK9 inhibitor and oestrogen shared similar efficacy in the attenuation in cardiometabolic impairment in ovariectomized prediabetic rats.
Journal ArticleDOI
The effects of proprotein convertase subtilisin/kexin type 9 inhibitors on lipid metabolism and cardiovascular function.
Patchareeya Amput,Christian M. McSweeney,Siripong Palee,Arintaya Phrommintikul,Siriporn C. Chattipakorn,Nipon Chattipakorn +5 more
TL;DR: This review comprehensively summarizes and discusses the effects of PCSK9 inhibitors on lipid metabolism and cardiovascular function comparatively with current lipid lowering drugs.
Journal ArticleDOI
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor exerts greater efficacy than atorvastatin on improvement of brain function and cognition in obese rats.
Busarin Arunsak,Wasana Pratchayasakul,Patchareeya Amput,Kenneth Chattipakorn,Theetouch Tosukhowong,Sasiwan Kerdphoo,Thidarat Jaiwongkum,Chanisa Thonusin,Siripong Palee,Nipon Chattipakorn,Siriporn C. Chattipakorn +10 more
TL;DR: Interestingly, PCSK9 inhibitor had the greater efficacy than atorvastatin on the amelioration of hippocampal oxidative stress, blood brain barrier breakdown, microglial hyperactivity, synaptic dysplasticity in the hippocampus and cognitive decline.